Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05773885 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Telerehabilitation in People With Parkinson's Disease

Study acronym: TEMPO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Sep 30, 2023 to Mar 30, 2025
    • Study completion date: Mar 31, 2024 to Mar 31, 2026
    • Site details revised at 1 of 2 sites
    • Collaborators expanded, about 4 words
    v3
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Although TeleRehabilitation (TR) is widely accepted as an appropriate model for the provision of professional health services in the field of physiotherapy, with already established standards, guidelines and policies, there are still few studies in the literature on the use of TR as a rehabilitation tool in people with Parkinson's Disease (PD). Therefore, further studies on the efficacy of TR in the management of motor and non-motor symptoms of PD are needed. The study TEMPO aims at assessing the efficacy (in terms of autonomy in carrying out the activities of daily life) of a home TR program based on serious games in people with PD compared to conventional day-hospital treatment.
Trial Details
NCT Number NCT05773885
Lead Sponsor IRCCS San Raffaele Roma
Collaborators: Ministry of Health, Italy
Conditions
(from sponsor)		 Parkinson's Disease
Related terms Parkinson Disease, Patient Compliance
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov